TP53 and neoplasm: Most tumor cell lines suffer from a TP53 mutant gene, making the early/low dose (0.5–1.5 Gy) radiation response more gradual without LDHS and low-dose LDA, as shown in the cell survival insert in Figure 1 (cf also Section 2.4 and Section 2.6 Figures below).